IBAB Ion Beam Applications SA

Iba – Transparency Notification

Iba – Transparency Notification

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)

Louvain-la-Neuve, Belgium, October 26, 2023 18:00

Summary of the notification

ION BEAM APPLICATIONS SA ("IBA") announces that it is required to make a transparency notification in accordance with Article 14, paragraph 1, of the Law on the Disclosure of Major Shareholdings in Issuers whose Shares are admitted to Trading on a Regulated Market and on Miscellaneous Provisions (the "Transparency Law"), following the notification dated October 24, 2023.

In its notification, MANAGEMENT ANCHORAGE SRL (BCE 0743.981.288) announces that it has acquired 348,530 shares on 30/08/2021. Pursuant to Article 28 of the Articles of Association concerning double voting rights, and following the expiry of the two-year holding period provided for by this statutory provision, this shareholder announces that it has exceeded the statutory threshold of 1% on 30/08/2023.

Content of the notification

  • Reason for the notification: Passive crossing of a threshold
  • Notification by: A person who notifies alone
  • Persons subject to the notification requirement:
  • Date on which the threshold is crossed: 30/08/2023
  • Threshold crossed (in %) : 1%
  • Denominator : 40.595.290
  • Notified details: (extract of the received notification form)
  • Full chain of controlled undertakings through which the holding is effectively held

Management Anchorage SRL is not controlled.

  • Additional information

On 08/30/2021, Management Anchorage SRL (BCE 0743.981.288, incorporated under the name "IB Anchorage") acquired 348,530 registered shares. In accordance with Article 28 of IBA SA's Articles of Association concerning double voting rights, Management Anchorage SRL has held 697,060 voting rights since 30/08/2023, i.e. 1.72%.

Shares with loyalty voting rights (article 28 of the Articles of Association): registered shares recorded in the register for at least two consecutive years in the name of their holder (see article 7:53 of the Companies and Associations Code).  Following the introduction of loyalty voting rights by decision of the General Meeting of March 10, 2020, the calculation method adopted by IBA to determine the number of shares with loyalty voting rights at any given time is the LIFO (last in, first out) method, i.e. for the same registered shareholder, the shares that the latter acquired most recently are the first shares to be deducted from his or her “portfolio” of registered shares if he or she subsequently sells shares.

Statutory transparency thresholds (article 35 of the bylaws): "In accordance with Article 18 of the Law of May 2, 2007 on the disclosure of major shareholdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions, the notification obligation provided for in Articles 6 et seq. of this law applies to the crossing, upwards or downwards, of any minimum percentage of one percent (1%), two percent (2%), three percent (3%), four percent (4%), five percent (5%), seven point five percent (7. 5%), and at percentages of ten percent (10%), fifteen percent (15%) and so on in increments of five percent (5%), of the total voting rights outstanding at the time of the occurrence of the situation giving rise to the declaration under this law".

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals, and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2.000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

For further information, please contact:

Valérie Van Impe

Paralegal



_______________

 

Attachment



EN
26/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

Guy Sips ... (+9)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : ABI BB, AGN NA, ARCAD NA, BESI NA, ENX FP, GIMB BB, HY...

: ABI BB, AGN NA, ARCAD NA, BESI NA, ENX FP, GIMB BB, HYL BB, IBAB BB, KIN BB, MTLS US, VGP BB, AZE BB, ZEAL DC

 PRESS RELEASE

IBA and Shreeji sign multi‑site agreement for four cyclotrons to expan...

IBA and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India Louvain-la-Neuve, Belgium – 19 February 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, and Shreeji (Shreeji Imaging and Diagnostic Centre Pvt. Ltd.), a leading Indian manufacturer and distributor of fluorodeoxyglucose (FDG) and positron emission tomography (PET) radiopharmaceuticals, have signed a multi-site agreement for the delivery and installation of four mid-en...

 PRESS RELEASE

IBA et Shreeji signent un accord pour quatre cyclotrons afin d’étendre...

IBA et Shreeji signent un accord pour quatre cyclotrons afin d’étendre la production de radiopharmaceutiques TEP en Inde Louvain-la-Neuve, Belgium – 19 février 2026 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d'accélérateurs de particules et acteur de premier plan en médecine nucléaire, et Shreeji (Shreeji Imaging and Diagnostic Centre Pvt. Ltd.), l'un des principaux fabricants et distributeurs indiens de fluorodéoxyglucose (FDG) et de radiopharmaceutiques pour la tomographie par émission de positons (TEP), ont signé un contrat pour la livraison et l'i...

 PRESS RELEASE

IBA – ACQUISITION OF OWN SHARES

IBA – ACQUISITION OF OWN SHARES Louvain-la-Neuve, Belgium, February 16th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026. Under this program, IBA has requested a financial intermediary to repurchase up to 400,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until September 30th, 2026 (included), effective as from February 3rd, 2...

 PRESS RELEASE

IBA – ACQUISITION D’ACTIONS PROPRES

IBA – ACQUISITION D’ACTIONS PROPRES Louvain-la-Neuve, Belgique, 16 février 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 2 février 2026. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 400.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 30 septembre 2026 et effectif ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch